Amoeba SA (ALMIB) - Total Liabilities

Latest as of December 2025: €15.49 Million EUR ≈ $18.11 Million USD

Based on the latest financial reports, Amoeba SA (ALMIB) has total liabilities worth €15.49 Million EUR (≈ $18.11 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset momentum of Amoeba SA to track the company's year-over-year net asset growth rate.

Amoeba SA - Total Liabilities Trend (2011–2025)

This chart illustrates how Amoeba SA's total liabilities have evolved over time, based on quarterly financial data. See Amoeba SA free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Amoeba SA Competitors by Total Liabilities

The table below lists competitors of Amoeba SA ranked by their total liabilities.

Company Country Total Liabilities
AV Tech Corp
TW:8072
Taiwan NT$241.48 Million
Forian Inc
NASDAQ:FORA
USA $14.35 Million
Lokman Hekim Engurusag Saglik Turizm Egitim Hizmetleri ve Insaat Taahhut AS
IS:LKMNH
Turkey TL2.76 Billion
ETHZilla Corporation
NASDAQ:ETHZ
USA $66.88 Billion
Great Elm Group Inc
NASDAQ:GEG
USA $71.94 Million
TEKNA HOLDING ASA NK 2
F:8VB
Germany €18.33 Million
Korea Computer & Systems Inc
KQ:115500
Korea ₩7.26 Billion
Lithium Ionic Corp
V:LTH
Canada CA$36.02 Million

Liability Composition Analysis (2011–2025)

This chart breaks down Amoeba SA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Amoeba SA worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.98 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity -2.89 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 1.53 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Amoeba SA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Amoeba SA (2011–2025)

The table below shows the annual total liabilities of Amoeba SA from 2011 to 2025.

Year Total Liabilities Change
2025-12-31 €15.49 Million
≈ $18.11 Million
-3.54%
2024-12-31 €16.06 Million
≈ $18.78 Million
+56.99%
2023-12-31 €10.23 Million
≈ $11.96 Million
+141.99%
2022-12-31 €4.23 Million
≈ $4.94 Million
-70.44%
2021-12-31 €14.30 Million
≈ $16.72 Million
+29.28%
2020-12-31 €11.06 Million
≈ $12.93 Million
+15.09%
2019-12-31 €9.61 Million
≈ $11.24 Million
+112841.62%
2018-12-31 €8.51K
≈ $9.95K
-6.05%
2017-12-31 €9.06K
≈ $10.59K
+93.31%
2016-12-31 €4.69K
≈ $5.48K
+32.52%
2015-12-31 €3.54K
≈ $4.13K
-99.87%
2014-12-31 €2.75 Million
≈ $3.22 Million
+52.76%
2013-12-31 €1.80 Million
≈ $2.11 Million
+133.74%
2012-12-31 €770.75K
≈ $901.09K
+16.57%
2011-12-31 €661.17K
≈ $772.98K
--

About Amoeba SA

PA:ALMIB France Agricultural Inputs
Market Cap
$67.11 Million
€57.40 Million EUR
Market Cap Rank
#20749 Global
#324 in France
Share Price
€0.74
Change (1 day)
+1.10%
52-Week Range
€0.66 - €1.16
All Time High
€38.22
About

Amoéba S.A. develops biological products and services for the treatment of microbiological risk in the sectors of water, health, and plant protection in France. The company has developed technology to treat water, surfaces, and chronic wounds that uses the natural biocidal capacity of the living amoeba Willaertia magna C2c Maky; and agriculture biocontrol technology for the treatment of phytopath… Read more